The American Association of Endocrine Surgeons, Patient Education Site

Management of metastatic disease from neuroendocrine cancers

This document is available in Spanish

Suggested References

Gupta, S, Yao, J, Ahrar, K, et al. Hepatic artery embolization and chemoembolization for treatment of patients with metastatic carcinoid tumors: the MD Anderson experience. Cancer J 2003; 9:261.

King, J, Quinn, R, Glenn, DM, et al. Radioembolization with selective internal radiation microspheres for neuroendocrine liver metastases. Cancer 2008; 113:921.

Kulke, MH, Hornick, JL, Frauenhoffer, C, et al. O6-methylguanine DNA methyltransferase deficiency and response to temozolomide-based therapy in patients with neuroendocrine tumors. Clin Cancer Res 2009; 15:338.

Kwekkeboom DJde Herder W, Kam B, et al. Treatment with the radiolabeled aomatostatin analog [177 Lu-DOTA 0, Tyr3] octreotate: toxicity, efficacy, and survival. Journal of Clinical Oncology 2008; 26:2124-2130.

LeTreut Y, Gregoire E, Belghiti J, et al. Predictors of long-term survival after liver transplantation for metastatic endocrine tumors: an 85-case French multicentric report. American Journal of Transplantation 2008; 8: 1205-1213.

Musunuru, S, Chen, H, Rajpal, S, et al. Metastatic neuroendocrine hepatic tumors: resection improves survival. Arch Surg 2006; 141:1000.

Rinke, A, Muller, HH, Schade-Brittinger, C, et al. Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group. J Clin Oncol 2009; 27:4656.

Rhee, TK, Lewandowski, RJ, Liu, DM, et al. 90Y Radioembolization for metastatic neuroendocrine liver tumors: preliminary results from a multi-institutional experience. Ann Surg 2008; 247:1029.

Sarmiento, JM, Heywood, G, Rubin, J, et al. Surgical treatment of neuroendocrine metastases to the liver: a plea for resection to increase survival. J Am Coll Surg 2003; 197:29.

Siperstein, AE, Berber, E. Cryoablation, percutaneous alcohol injection, and radiofrequency ablation for treatment of neuroendocrine liver metastases. World J Surg 2001; 25:693.

back to Top


Find an Experienced Endocrine Surgeon


Visit Endocrine Patient Resources Page